We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 30, 2018 | Series Unknown | $6M | 1 | SICAR | — | Detail |
Dec 23, 2015 | Series Unknown | $10M | 1 | InterCure | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Oct 28, 2021
nft42
|
Seed | $3.50M | Art | — |
Aug 10, 2021
Saturn Technologies
|
Series Unknown | $44M | Apps | — |
Mar 30, 2021
SuperRare
|
Series A | $9M | Bitcoin | — |
Jan 1, 2021
NCX
|
Seed | $4.40M | Biometrics | — |
Dec 3, 2020
NCX
|
Seed | $4.39M | Biometrics | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
SICAR | Yes | Series Unknown |
InterCure | Yes | Series Unknown |